» Articles » PMID: 22698470

Relationship Between Serum Vitamin D and 24-hour Urine Calcium in Patients with Nephrolithiasis

Overview
Journal Urology
Specialty Urology
Date 2012 Jun 16
PMID 22698470
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the relationship between serum 25-OH vitamin D and 24-hour urine calcium in patients with nephrolithiasis.

Methods: A retrospective review was performed. Patients evaluated in 2 metabolic stone clinics were included for analysis. Multivariate linear regression models were adjusted for known risk factors for stone disease (age, gender, body mass index, hypertension, diabetes mellitus, gout, relevant medications, and 24-hour urine composition).

Results: One-hundred sixty-nine patients were included in the study. Female to male ratio was 69:100, mean age was 50.9 years (SD 13.7), and mean body mass index was 27.4 (SD 6.4). Vitamin D deficiency (25-OH vitamin D <20 ng/mL) was present in 18.9% of patients, vitamin D insufficiency (>20, <30 ng/mL) was present in 34.9% of patients, and vitamin D was within normal limits (≥ 30 ng/mL) in 46.1% of patients. On age-adjusted and multivariate linear regression, serum 25-OH vitamin D was not related to 24-hour urine calcium (age adjusted β = -0.31 m 95% CI -1.9 to 1.3; multivariate adjusted β = 0.08, 95% CI -1.3 to 1.5).

Conclusion: Although 25-OH vitamin D is involved in the body's calcium homeostasis, our study does not show a relationship between serum vitamin D level and 24-hour urine calcium excretion in stone-formers. This information may have implications regarding the safety of vitamin D repletion in patients with nephrolithiasis.

Citing Articles

Sleep and circadian rhythm disturbance in kidney stone disease: a narrative review.

He S, Wang J, Li T, Yin S, Cui J, Xiao Y Front Endocrinol (Lausanne). 2023; 14:1293685.

PMID: 38089624 PMC: 10711275. DOI: 10.3389/fendo.2023.1293685.


A path analysis to investigate the interaction between serum, urinary and demographic factors influencing urine calcium in kidney stone formers.

Taheri F, Taheri M, Tavasoli S, Basiri A, Borumandnia N Int Urol Nephrol. 2023; 55(7):1829-1836.

PMID: 36780048 DOI: 10.1007/s11255-023-03461-z.


Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.

Aliberti L, Gagliardi I, Gamberini M, Ziggiotto A, Verrienti M, Carnevale A Br J Haematol. 2022; 198(5):903-911.

PMID: 35768889 PMC: 9542302. DOI: 10.1111/bjh.18345.


UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.

Bhojani N, Bjazevic J, Wallace B, Lee L, Kaler K, Dion M Can Urol Assoc J. 2022; 16(6):175-188.

PMID: 35623003 PMC: 9245965. DOI: 10.5489/cuaj.7872.


Effect of Vitamin D Treatment on Dynamics of Stones Formation in the Urinary Tract and Bone Density in Children with Idiopathic Hypercalciuria.

Milart J, Lewicka A, Jobs K, Wawrzyniak A, Majder-Lopatka M, Kalicki B Nutrients. 2020; 12(9).

PMID: 32825353 PMC: 7551195. DOI: 10.3390/nu12092521.